Survival of pediatric population with acute lymphoblastic leukemia treated with ALLIC-BFM chemotherapy protocol. Systematic review
DOI:
https://doi.org/10.37135/ee.04.16.09Keywords:
Leukemia, Lymphoid, Survival Analysis, Drug Therapy, ChildAbstract
Acute lymphoblastic leukemia is the most common childhood neoplasia. Current treatments allow more than 80% disease-free survival for five years. In 2000, a chemotherapy protocol called Berlin-Frankfurt-Münster intercontinental lymphoblastic leukemia (ALLIC BFM) was tested. The investigative process was carried out using the PRISMA methodology. This study aimed to systematize the information about the survival of pediatric patients with acute lymphoblastic leukemia treated with the ALLIC BFM chemotherapy protocol in its 2002 or 2009 versions. 52% to 91.7% of patients showed an overall survival in patients where the 2002 protocol was used, and disease-free was from 45% to 83.3%; while, with the use of the 2009 protocol, an overall survival of 71.1% to 90% was reported, and disease-free survival was 69.4% to 90.3%. The main factors affecting survival were treatment-related complications, high-risk patients, and insufficient medication.
Downloads
References
Mancero-Rodríguez MJ, Arellano-Salinas KP, Santos-Cepeda KA, Rodríguez-Revelo ME. Leucemia linfoblástica aguda diagnostico - Acute lymphoblastic leukemia diagnosis. Recimundo [Internet]. 2020 [citado 2022 Jun 4]; 4(2): 53-63. Disponible en: http://recimundo.com/index.php/es/article/view/822%0Ahttp://www.recimundo.com/index.php/es/article/view/822.
Bonilla-García CD. Análisis de supervivencia de los pacientes con diagnóstico de leucemia linfoblástica tratados Hospital Oncológico Solón Espinosa Ayala (SOLCA) núcleo Quito en el período 2000 – 2017 [tesis en Internet]. Quito: Pontificia Universidad Católica del Ecuador; 2019 [citado 2022 May 4]. Disponible en: http://repositorio.puce.edu.ec/bitstream/handle/22000/16462/TESIS%CINDY%BONILLA.pdf?sequence=1&isAllowed=y.
Sunamak EÇ, Özdemir N, Koka A, Yantiri L, Apak H, Celkan T. Comparison of outcomes of children with acute lymphoblastic leukemia treated with BMF protocol across 2 decades. Pediatr Hematol Oncol [Internet]. 2020 [citado 2022 Jun 5]; 38(2): 134-146. Disponible en: https://www.tandfonline.com/doi/full/10.1080/08880018.2020.1825573.
Chargoy-Vivaldo E, Martínez-Hernández C, Cacique-Sánchez C, Jimaréz-Rodríguez JM, Gómez-Cárdenas L. Translocaciones en leucemia linfoblástica aguda y supervivencia a cinco años en niños - Translocations in acute lymphoblastic leukemia and five. Rev Hematol Mex [Internet]. 2018 [citado 2022 Jun 2]; 19(4): 165-173. Disponible en: https://www.medigraphic.com/pdfs/hematologia/re-2018/re184b.pdf.
Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol [Internet]. 2018 [citado 2022 Jun 6]; 5(1): e14-24. Disponible en: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(17)30232-6/fulltext.
Ward ZJ, Yeh JM, Bhakta N, Frazier AL, Atun R. Estimating the total incidence of global childhood cancer: a simulation-based analysis. Lancet Oncol [Internet]. 2019 [citado 2022 May 7]; 20(4): 483-493. Disponible en: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30909-4/fulltext.
Barchi-Salas OE, Zuñiga-Mendez CR. Manifestaciones clínicas tempranas de leucemia linfoblástica aguda e incidencia en menores de 5 años de edad [tesis en Internet]. Guayaquil: Universidad de Guayaquil; 2018 [citado 2022 Jul 8]. Disponible en: http://repositorio.ug.edu.ec/handle/redug/30597.
Zuluaga-Liberato AM, Guavita-Navarro DK. Supervivencia en una cohorte de pacientes con adenocarcinoma gástrico resecable, Bogotá, 2005-2018 [tesis en Internet]. Bogotá: Universidad del Rosario; 2019 [citado 2022 May 27]. Disponible en: https://repository.urosario.edu.co/bitstream/handle/10336/19102/ZuluagaLiberato-AndreaMarcela-2019.pdf?sequence=4&isAllowed=y.
Campbell M, Castillo L, Cecilia Riccheri D, Janez-Jazbec A, Kaiserova E, Konja J, et al. A Randomized Trial of the I-BFM-SG for the Management of Childhood non-B Acute Lymphoblastic Leukemia [monografía en Internet]. 2015 [citado 2022 Sep 4]. Disponible en: https://www.bialaczka.org/wp-content/uploads/2016/10/ALLIC_BFM_2009.pdf.
García-Caraballoso MB, Hernández TC, Martínez-Cárdenas L. Repercusión del desarrollo científico técnico en la supervivencia de pacientes pediátricos con leucemia linfoide aguda. Acta Médica del Centro [Internet]. 2020 [citado 2022 May 8]; 14(1): 126-132. Disponible en: http://scielo.sld.cu/pdf/amdc/v14n1/2709-7927-amdc-14-01-126.pdf.
Velasco-Puyó P, Murillo-Sanjuán L. Leucemia aguda en Pediatría. Pediatr Integral [Internet]. 2021 [citado 2022 May 11]; XXV(6): 296-307. Disponible en: https://www.pediatriaintegral.es/publicacion-2021-09/leucemia-aguda-en-pediatria/#:~:text=La%20leucemia%20aguda,de%20diferenciaci%C3%B3n%20a%20c%C3%A9lulas%20normales.
Halfon-Domenech C. Leucemia linfoblástica aguda del niño y el adolescente. EMC Pediatr [Internet]. 2021 mar [citado 2022 May 19]; 56(1): 1-9. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S1245178921447207.
Transparent reporting of systematic reviews and meta-analyses [Internet]. Washington: Prisma-statement. 2020 [actualizado 2021 Ene 28; citado 2022 Jun 21]. Disponible en: https://prisma-statement.org//.
Study Quality Assessment Tools [Internet]. Washington: NIH; 2021 [actualizado 2021 Jun 1; citado 2022 May 12]. Disponible en: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
Bonilha TA, Obadia DDA, Valveson AC, Land MGP. Outcome of childhood acute lymphoblastic leukemia treatment in a single center in Brazil: A survival analysis study. Cancer Rep (Hoboken) [Internet]. 2022 [citado 2022 May 29]; 5(1): e1452. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789616/pdf/CNR2-5-e1452.pdf.
González-Otero A, Otero AG, Núñez AA, García SM, Veitía AM, Díaz AIG, et al. Protocolo ALLIC-BFM 2002 en el Instituto de Hematología e Inmunología: experiencia de 10 años. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2016 [citado 2022 Jun 19]; 32(1): 70-85. Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/311.
Fernández-Villalón M, Pérez-Medina Y, Urgellés-Díaz D, Fernández-Villalón M. Supervivencia de niños y adolescentes con leucemia linfoblástica aguda. Medisan [Internet]. 2019 [citado 2022 Jun 6]; 23(3): 412-423. Disponible en: http://scielo.sld.cu/pdf/san/v23n3/1029-3019-san-23-03-412.pdf.
Jovanovska A, Trakova-Antevska Z, Kocheva S, Stankovikj S, Panovska-Stavridis I, Dimovski A, et al. Clinical characteristics and treatment results of childhood Acute Lymphoblastic Leukemia in North Macedonia. Prilozi [Internet]. 2020 [citado 2022 Jul 12]; 41(2): 37-47. Disponible en: https://sciendo.com/article/10.2478/prilozi-2020-0031.
Kolenova A, Kaiserova E, Makohusova M, Subova Z, Bubanska E, Oravkinova I, et al. Improved outcome for children and adolescent with acute lymphoblastic leukemia in the first decade of the 21st century: a report from the Slovak Republic. Neoplasma [Internet]. 2015 [citado 2022 Jun 24]; 62(5): 812-820. Disponible en: http://www.elis.sk/download_file.php?product_id=4340&session_id=ags76nbchc47i59h7jdu952bg6.
Kowalczyk JR, Zawitkowska J, Lejman M, Drabko K, Samardakiewicz M, Matysiak M, et al. Long-term treatment results of Polish pediatric and adolescent patients enrolled in the ALL IC-BFM 2002 trial. Am J Hematol [Internet]. 2019 [citado 2022 May 17]; 94(11): E307-10. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852109/pdf/AJH-94-E307.pdf.
Alecsa MS, Moscalu M, Trandafir LM, Ivanov AV, Rusu C, Miron IC. Outcomes in pediatric acute lymphoblastic leukemia—A single-center romanian experience. J Clin Med [Internet]. 2020 [citado 2022 Jul 19]; 9(12): 1-14. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765371/pdf/jcm-09-04052.pdf.
Styczyński J, Jatczak-Gaca A, Matiakowska K, Bartoszewska-Kubiak A, Kołtan A, Dębski R, et al. Prognostic significance of BCR-ABL rearrangement in childhood acute lymphoblastic leukemia. Med and Biolog Sci [Internet]. 2014 [citado 2022 May 14]; 28(4): 49-55. Disponible en: https://apcz.umk.pl/MBS/article/view/MBS.2014.034/4865.
Volejnikova J, Jarosova M, Pospisilova D, Novak Z, Vrbkova J, Hajduch M, et al. Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: A retrospective single-center study from Olomouc, Czech Republic. Neoplasma [Internet]. 2016 [citado 2022 Jul 23]; 63(3): 456-469. Disponible en: http://www.elis.sk/download_file.php?product_id=4701&session_id=ags76nbchc47i59h7jdu952bg6.
Jatczak-Gaca A, Styczynski J, Koltan A, Debski R, Pogorzala M, Wysocki M. Results of therapy in children with acute lymphoblastic leukemia in over 50 years of experience in a single center in Poland. Leuk Lymphoma [Internet]. 2015 [citado 2022 May 19]; 56(7): 2212-2214. Disponible en: https://www.tandfonline.com/doi/full/10.3109/10428194.2014.999325?scroll=top&needAccess=true.
Gao YJ, Qian XW, Lu FJ, Zhai XW, Wang HS, Li J. Improved outcome for children with non-high risk acute lymphoblastic leukaemia after using an ALL IC-BFM 2002-based protocol in Shanghai, China. Br J Haematol [Internet]. 2013 [citado 2022 Jul 7]; 160(3): 363-367. Disponible en: https://onlinelibrary.wiley.com/doi/10.1111/bjh.12122.
Stary J, Zimmermann M, Campbell M, Castillo L, Dibar E, Donska S, et al. Intensive chemotherapy for childhood acute lymphoblastic leukemia: Results of the randomized intercontinental trial ALL IC-BFM 2002. J Clin Oncol [Internet]. 2014 [citado 2022 Jul 4]; 32(3): 174-184. Disponible en: https://ascopubs.org/doi/pdf/10.1200/JCO.2013.48.6522.
Trujillo ÁM, Linares A, Sarmiento IC. Intensive chemotherapy in children with acute lymphoblastic leukemia. Interim analysis in a referral center in Colombia. Rev Fac Med [Internet]. 2016 [citado 2022 May 20]; 64(3): 417-425. Disponible en: http://www.scielo.org.co/pdf/rfmun/v64n3/0120-0011-rfmun-64-03-00417.pdf.
Ozaeta D, Casallas A, Martínez L, Castillo A, Baquero O, Cobos O. Supervivencia de los niños con Leucemia Linfoide Aguda manejados con protocolo basado en ALL-IC-BFM 2009 en Bogotá D.C. Colombia. Pediatr [Internet]. 2021 [citado 2022 Jul 14]; 53(4): 145-152. Disponible en: https://revistapediatria.org/rp/article/view/205#:~:text=Resultados%3A%20La%20supervivencia%20global%20para,el%20grupo%20de%20riesgo%20alto.
Burnusuzov H, Spasova M, Stoyanova A, Mumdjiev I, liliya I, Spasov N. Treatment of children with Acute Lymphoblastic Leukemia assisted by flow cytometric evaluation of minimal residual disease - A single centre experience. Clin Lymphoma Myeloma Leuk [Internet]. 2018 [citado 2022 Jun 20]; 18(September). Disponible en: https://www.clinical-lymphoma-myeloma-leukemia.com/article/S2152-2650(18)30766-3/fulltext.
Zawitkowska J, Lejman M, Romiszewski M, Matysiak M, Ćwiklińska M, Balwierz W, et al. Results of two consecutive treatment protocols in Polish children with acute lymphoblastic leukemia. Sci Rep [Internet]. 2020 [citado 2022 Jun 27]; 10(1): 1-9. Disponible en: https://www.nature.com/articles/s41598-020-75860-6.
Kumar-Nath U, Chattopadhyay D, Bakliwal A, Vaniyath S, Chetia R, Rajoreya AK. Encouraging results with ALL IC-BFM 2009 protocol therapy in pediatric Acute Lymphoblastic Leukemia/Lymphoma in resource-limited setting: A single-center study from India. Blood [Internet]. 2019 [citado 2022 Jun 19]; 134(1): 5118. Disponible en: https://ashpublications.org/blood/article/134/Supplement_1/5118/424862/Encouraging-Results-with-ALL-IC-BFM-2009-Protocol.
.Aytekin S, Aytekin G, Tokgöz H, Çalışkan M. Acute Lymphoblastic Leukemia in childhood: single center 10 years experience: retrospective analysis. Ann Med Res [Internet]. 2019 [citado 2022 Jun 19]; 26(12): 2928-2936. Disponible en: https://www.ejmanager.com/mnstemps/134/134-1569825979.pdf?t=1662439883.
Querol-Betancourt N, Chávez-Isla MI, Leblanch-Fernández CC, Jimenez-Portuondo N. Caracterización clínico epidemiológica y supervivencia de pacientes menores de 19 años con leucemia. MEDISAN [Internet]. 2021 [citado 2022 Jul 29]; 25(1): 26-40. Disponible en: http://scielo.sld.cu/pdf/san/v25n1/1029-3019-san-25-01-26.pdf.
Winestone LE, Aplenc R. Disparities in survival and health outcomes in childhood Leukemia. Curr Hematol Malig Rep [Internet]. 2019 [citado 2022 Oct 22]; 14(3): 179-186. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31073772/.
Kahn JM, Cole PD, Blonquist TM, Stevenson K, Jin Z, Barrera S, et al. An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana-Farber Cancer Institute ALL Consortium protocol 05-001. Pediatr Blood Cancer [Internet]. 2018 [citado 2022 May 16]; 65(3): 139-148. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/pbc.26871.
Rojas-Soto N, Moreno-Larrea M, Pizarro-Perea M, Aranda-Gomero L, Arteta-Altamirano C, Eyzaguirre-Zapata R, et al. Guía de Práctica Clínica para el manejo de pacientes con Leucemia Linfoblástica Aguda en el Seguro Social del Perú (EsSalud). Acta Med Peru [Internet]. 2021 [citado 2022 Jul 24]; 38(1): 64-78. Disponible en: http://www.scielo.org.pe/pdf/amp/v38n1/1728-5917-amp-38-01-64.pdf.
Recalde Bermeo MR, García Ríos CA, Criollo Criollo A del R. Calidad de vida en pacientes pediátricos tratados con quimioterapia por diagnóstico de leucemia linfoblástica aguda. Rev Eug Esp [Internet]. 2022 [citado 2022 May 20]; 16(1): 29-38. Disponible en: https://eugenioespejo.unach.edu.ec/index.php/EE/article/view/436/62.
Abdelmabood S, Fouda AE, Boujettif F, Mansour A. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival. J Pediatr (Rio J) [Internet]. 2020 [citado 2022 Jul 14]; 96(1): 108-116. Disponible en: https://reader.elsevier.com/reader/sd/pii/S0021755718305837?token=97AEAEC5DED8A5B645D0B83E210EBCF164F7A23A0E8289176F585F11CC064E5353953AEF7699DF0B6040CFF7157E24B8&originRegion=us-east-1&originCreation=20220906051021.
Wu YP, Stenehjem DD, Linder LA, Yu B, Parsons BG, Mooney R, et al. Adherence to oral medications during maintenance therapy among children and adolescents with Acute Lymphoblastic Leukemia: A medication refill analysis. J Pediatr Oncol Nurs [Internet]. 2018 [citado 2022 Jul 7]; 35(2): 86-93. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5935503/pdf/10.1177_1043454217741877.pdf.
Pedersen LH, Ostergaard A, Bank V, Nersting J, Tuckuviene R, Skov Wehner P, et al. Socioeconomic position and maintenance therapy in children with acute lymphoblastic leukemia: A national cohort study. Pediatr Blood Cancer [Internet]. 2022 [citado 2022 Jul 22]; 69(7): e29508. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/pbc.29508.
Puła A, Zdunek M, Michalczyk K, Cichosz M, Młynarski W. Chemotherapy delays in children with acute lymphoblastic leukemia might influence the outcome of treatment. Acta Haematol Pol [Internet]. 2022 [citado 2022 Jul 5]; 53(2): 141-148. Disponible en: https://journals.viamedica.pl/acta_haematologica_polonica/article/view/75836.
Alsultan A, Abdullah A, Ayas M, Alharbi M, Alkhayat N, Al-Anzi F, et al. Travel burden and geographic access to health care among children with cancer in Saudi Arabia. East Mediterr Health J [Internet]. 2020 [citado 2022 Jul 15]; 26(11): 1355-1362. Disponible en: http://www.emro.who.int/images/stories/emhj/documents/in_press/travel_burden_and_geographic_access_to_health_care_among_children_with_cancer_in_saudi_arabia.pdf.
Rotz SJ, Wei W, Thomas SM, Hanna R. Distance to treatment center is associated with survival in children and young adults with Acute Lymphoblastic Leukemia. Cancer [Internet]. 2020 [citado 2022 Jul 21]; 126(24): 5319-5327. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686274/pdf/nihms-1630083.pdf.
Schraw JM, Peckham-Gregory EC, Rabin KR, Scheurer ME, Lupo PJ, Oluyomi A. Area deprivation is associated with poorer overall survival in children with acute lymphoblastic leukemia. Pediatr Blood Cancer [Internet]. 2020 [citado 2022 Jul 24]; 67(9): 1-10. Disponible en: https://onlinelibrary.wiley.com/doi/10.1002/pbc.28525.
Additional Files
Published
Issue
Section
License
Copyright (c) 2022 Revista Eugenio Espejo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
